The focus on distribution implies that CD19 continues to be the central axis of innovation, but the sector is actively diversifying. A major preclinical and early medical thrust aims to mitigate antigen escape by means of twin-targeting or multi-focusing on patterns.Not sure if Automobile-T therapy in China is correct for the circumstance? … Read More